EUVIMEDObjevte EUVIMED
Crossref

Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach.

Yong Yu iD, Yoshihisa Koyama iD, Shoichi Shimada iD

Behavioral Neuroscience · 2026

DOI: 10.1037/bne0000653 ↗

At a glance

Journal article in Behavioral Neuroscience, 2026. Written by Yong Yu and 2 co-authors. Institution: Department of Neuroscience and Cell Biology, Graduate School of Medicine, University of Osaka. Major MEDLINE topics: Cisplatin, Avoidance Learning, Olfactory Perception, Smell. Cited 1 times so far (Crossref). Funded by: University of Osaka, Shandong Government, Shandong First Medical University.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Subjects

MeSH terms (MEDLINE)

CisplatinAvoidance LearningOlfactory PerceptionSmellAnimalsMaleMiceOdorantsChoice BehaviorPentanolsBenzaldehydesAntineoplastic Agents

Substances

CisplatinPentanolsBenzaldehydesAntineoplastic Agentsisoamyl acetatebenzaldehyde

Authors and institutions

  • Department of Neuroscience and Cell Biology, Graduate School of Medicine, University of Osaka.

ORCID profiles: Yong Yu, Yoshihisa Koyama, Shoichi Shimada

Funding

  • University of Osaka
  • Shandong Government
  • Shandong First Medical University

Cite

APA

Yu, Y., Koyama, Y., & Shimada, S. (2026). Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach. Behavioral Neuroscience. https://doi.org/10.1037/bne0000653

Vancouver

Yu Y, Koyama Y, Shimada S. Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach. Behavioral Neuroscience. 2026. doi:10.1037/bne0000653

BibTeX
@article{Yu2026,
  author = {Yu, Yong and Koyama, Yoshihisa and Shimada, Shoichi},
  title = {Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach},
  journal = {Behavioral Neuroscience},
  year = {2026},
  doi = {10.1037/bne0000653}
}
Start for free →